GCRI · Biotechnology and Biosecurity
Biotechnology platforms at Biotechnology and Biosecurity
How biotechnology platforms is applied in Biotechnology and Biosecurity. Biotechnology platforms apply biological systems to produce medicines, diagnostics, materials and agricultural products. They expand response capacity for health threats while introducing dual-use and biosafety concerns.
Biotechnology platforms at Biotechnology and Biosecurity on the record.
- MethodBiotechnology platforms
- نگرانحیاتیاتی ٹیکنالوجی اور حیاتیاتی تحفظ
- Applied inBiotechnology and Biosecurity
- Data5 inputs
- ChecksValidation
- Canonical pageSTEM Commons
What biotechnology platforms does here.
Biotechnology platforms apply biological systems to produce medicines, diagnostics, materials and agricultural products. They expand response capacity for health threats while introducing dual-use and biosafety concerns. In health and biosecurity and food and agriculture, biotechnology capacity shapes how quickly countermeasures can be produced in a crisis. Its supply chains and dual-use potential are part of biosecurity planning. The canonical description is on the STEM Commons.
- 01
Methods used here
genetic engineering; bioprocess design; high-throughput screening; diagnostic assay development; vaccine platform development; biosafety risk assessment.
- 02
توثیق
Products are evaluated through staged preclinical and clinical testing and manufacturing quality controls. Regulatory review and independent replication check claims.
SEIR on a network of places.
An outbreak seeded in one place spreads through a small-world network by the share of contacts people make elsewhere; play it to see the order of arrival and how the timing of measures moves the peak. Teaching model with stated illustrative values, not a prediction.
کنٹرولز
- بنیادی تولیدی عدد R0
- 2.5
- Latent period
- 3.0 days
- Infectious period
- 5.0 days
- Share of contacts made in other places
- 8%
- Places in the network
- 24
- Measures start on day
- 40
- Contact reduction from measures
- 40%
- Days simulated
- 240 days
ریڈنگز
- Peak new infections
- 3.97 per 1,000 a day
- Day of the peak
- 122
- Share ever infected
- 54%
- Places reached
- 100%
- Reproduction number under measures
- 1.50
اعداد، طریقے اور ماخذات
| دن | New infections per 1,000 | Cumulative infected (%) |
|---|---|---|
| 0 | 0.00 | 0.0 |
| 17 | 0.02 | 0.0 |
| 34 | 0.21 | 0.2 |
| 51 | 0.66 | 1.0 |
| 68 | 1.33 | 2.6 |
| 85 | 2.32 | 5.8 |
| 102 | 3.38 | 10.7 |
| 119 | 3.96 | 17.1 |
| 136 | 3.77 | 23.7 |
| 153 | 3.32 | 29.7 |
| 170 | 3.09 | 35.1 |
| 187 | 3.03 | 40.3 |
| 204 | 2.90 | 45.3 |
| 221 | 2.53 | 50.0 |
| 238 | 1.86 | 53.7 |
طریقے
- SEIR compartments Kermack and McKendrick (1927), Proc. R. Soc. A 115
- Metapopulation coupling by mobility Balcan and others (2009), PNAS 106
- Small-world network Watts and Strogatz (1998), Nature 393
- Modelling infectious diseases Keeling and Rohani (2008), Princeton University Press
- غیر یقینی کا پنکھا (پیرامیٹر Monte Carlo) Spiegelhalter، Pearson and Short (2011)، Visualising uncertainty about the future، Science 333
- ایک وقت میں ایک کی حساسیت (ٹورنیڈو) Saltelli and others (2008)، Global Sensitivity Analysis: The Primer، Wiley
ڈیٹا
The model runs on the teaching values set by the controls. To calibrate it for a place, read it against these admitted layers and series, which this page’s map can draw:
- Cities Natural Earth
- Airports Natural Earth
- Major roads Natural Earth
چھ ستونوں میں، Nexus Consortium کی قیادت میں
- تجربات تجربہ گاہیں
- Built in Biotechnology and Biosecurity in Foundry
- Tested at Biotechnology and Biosecurity in Universe
- Codified in Health and Biosecurity in Standards
- Published in Biotechnology and Biosecurity in Reports
- Taught in Faculty of Health and Society in Academy
What the method consumes.
Datasets and records used by biotechnology platforms on this platform, with the role each plays and the label its values carry. Sources are listed in the source register.
| ڈیٹا | کردار | لیبل |
|---|---|---|
| Laboratory automation systems | Input | مشاہدہ شدہ |
| Bioreactor process data | Input | مشاہدہ شدہ |
| Clinical trial registries | Input | مشاہدہ شدہ |
| Genomic databases | Input | مشاہدہ شدہ |
| Manufacturing quality records | Input | مشاہدہ شدہ |
The model, the data and the uncertainty.
The model, its assumptions, its data and its uncertainty, in the form a scientist or engineer would check. Structures follow published methods. The values drawn are illustrative, not findings.
Uncertainty bands
How far the outlook for Biotechnology platforms at Biotechnology and Biosecurity could spread, shown as ranges rather than a single line.
- Central estimate
- median of the ensemble
- Ranges
- likely and very likely, in IPCC calibrated language
- Ensemble
- members, scenarios and initial conditions stated
- Read with
- the sensitivity of the result to each input
How results are checked.
Products are evaluated through staged preclinical and clinical testing and manufacturing quality controls. Regulatory review and independent replication check claims.
Scale-up from laboratory to production often fails or takes time. Containment and oversight can lag behind technical capability.
Topics that rely on this method.
Who maintains the method.
Biotechnology and Biosecurity stewards biotechnology platforms for the Consortium and reviews how it is applied across platforms.
سوالات و جوابات۔
What are the limits of biotechnology platforms in this field?
How are results checked?
Are the values on this page real?
Where else is this method applied?
اس صفحے سے شواہد فراہم کریں۔
Reports کنسورشیم کی سہ ماہی اشاعت ہے۔ اس موضوع کے بارے میں آپ کا علم اگلے شمارے میں شواہد، کیس یا تصحیح بن سکتا ہے، جو آپ کے نام سے منسوب ہوگا اور اگر یہ آپ کا اپنا کام ہو تو CC BY 4.0 کے تحت شائع ہوگا۔
- EmailGateway GW-GCRISend it from this pageEvidence, a correction, a case, a method, a review, a translation or profile input. It arrives tagged with this page, so the editor who owns it receives it.
- ZenodoOpen depositDeposit it and submit to the communityPublish your own record on Zenodo with your ORCID iD, then submit it to the Reports community there. Curators review it; the DOI stays yours.
- رپورٹیںGCRIتعاون کے تمام طریقے دیکھیںتعاون کی اقسام، ہر ایک کا جائزہ کیسے لیا جاتا ہے، آپ کو کیا اعتراف ملتا ہے، لائسنس، اور کیا کبھی قبول نہیں کیا جاتا۔
کبھی بھی ذاتی ڈیٹا، حساس بنیادی ڈھانچے کی تفصیل یا کوئی ایسی چیز نہ بھیجیں جسے شیئر کرنے کا آپ کو حق نہ ہو۔ ہر شراکت استعمال سے پہلے جانچی جاتی ہے؛ اسے بھیجنے سے کوئی تصنیفی یا ادارتی حق حاصل نہیں ہوتا، اور سرپرستی کبھی کوئی نتیجہ نہیں خریدتی۔
Bring a method, a dataset or a question.
معلومات اور استفسارات آج کھلے ہیں۔ استفسار کو ایک حوالہ نمبر ملتا ہے اور اگلے مرحلے کی نشاندہی ہوتی ہے؛ درخواستیں، ادائیگیاں، کمپیوٹنگ کی تخصیص اور رجسٹریشن صرف اس وقت کھلتی ہیں جب ان کی ٹیم، شرائط اور جائزے کی استعداد موجود ہو۔
قانونی دستاویزات۔
اس سائٹ کے نقشے، ڈیٹا اور اشکال سیاق اور عمومی معلومات کے لیے دکھائے جاتے ہیں۔ یہ مشورہ، پیش گوئیاں یا انتباہات نہیں؛ معلومات کی حدود دستبرداریوں اور ڈیٹا سے متعلق اطلاعات میں بیان کی گئی ہیں۔